Report Detail
Global Pharmacogenomics Services Market Growth (Status and Outlook) 2022-2028
- RnM4387707 |
- 23 February, 2022 |
- Global |
- 113 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
As the global economy mends, the 2021 growth of Pharmacogenomics Services will have significant change from previous year. According to our (LP Information) latest study, the global Pharmacogenomics Services market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Pharmacogenomics Services market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Pharmacogenomics Services market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Pharmacogenomics Services market, reaching US$ million by the year 2028. As for the Europe Pharmacogenomics Services landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Pharmacogenomics Services players cover Abbott Laboratories, Admera Health, LLC, Mesa Laboratories, Inc., and Dynamic DNA Laboratories, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmacogenomics Services market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Genotyping
SNP Identification
Pharmacogenetic Testing
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Oncology
Infectious Diseases
Psychiatry
Cardiovascular
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Abbott Laboratories
Admera Health, LLC
Mesa Laboratories, Inc.
Dynamic DNA Laboratories
F. Hoffmann-La Roche Ltd.
GeneOmbio Technologies Pvt Ltd.
Exact Sciences Corporation
Illumina, Inc.
Laboratory Corporation of America Holdings
Myriad Genetics, Inc.
OmeCare
QIAGEN N.V.
Quest Diagnostics Incorporated
Thermo Fisher Scientific Inc.
Precipio
23andMe, Inc.
OneOme, LLC
DiaCarta, Inc.
OPKO Health
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Pharmacogenomics Services Market Size 2017-2028
- 2.1.2 Pharmacogenomics Services Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Pharmacogenomics Services Segment by Type
- 2.2.1 Genotyping
- 2.2.2 SNP Identification
- 2.2.3 Pharmacogenetic Testing
- 2.2.4 Others
- 2.3 Pharmacogenomics Services Market Size by Type
- 2.3.1 Pharmacogenomics Services Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Pharmacogenomics Services Market Size Market Share by Type (2017-2022)
- 2.4 Pharmacogenomics Services Segment by Application
- 2.4.1 Oncology
- 2.4.2 Infectious Diseases
- 2.4.3 Psychiatry
- 2.4.4 Cardiovascular
- 2.4.5 Others
- 2.5 Pharmacogenomics Services Market Size by Application
- 2.5.1 Pharmacogenomics Services Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Pharmacogenomics Services Market Size Market Share by Application (2017-2022)
3 Pharmacogenomics Services Market Size by Player
- 3.1 Pharmacogenomics Services Market Size Market Share by Players
- 3.1.1 Global Pharmacogenomics Services Revenue by Players (2020-2022)
- 3.1.2 Global Pharmacogenomics Services Revenue Market Share by Players (2020-2022)
- 3.2 Global Pharmacogenomics Services Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Pharmacogenomics Services by Regions
- 4.1 Pharmacogenomics Services Market Size by Regions (2017-2022)
- 4.2 Americas Pharmacogenomics Services Market Size Growth (2017-2022)
- 4.3 APAC Pharmacogenomics Services Market Size Growth (2017-2022)
- 4.4 Europe Pharmacogenomics Services Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Pharmacogenomics Services Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Pharmacogenomics Services Market Size by Country (2017-2022)
- 5.2 Americas Pharmacogenomics Services Market Size by Type (2017-2022)
- 5.3 Americas Pharmacogenomics Services Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Pharmacogenomics Services Market Size by Region (2017-2022)
- 6.2 APAC Pharmacogenomics Services Market Size by Type (2017-2022)
- 6.3 APAC Pharmacogenomics Services Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Pharmacogenomics Services by Country (2017-2022)
- 7.2 Europe Pharmacogenomics Services Market Size by Type (2017-2022)
- 7.3 Europe Pharmacogenomics Services Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Pharmacogenomics Services by Region (2017-2022)
- 8.2 Middle East & Africa Pharmacogenomics Services Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Pharmacogenomics Services Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Pharmacogenomics Services Market Forecast
- 10.1 Global Pharmacogenomics Services Forecast by Regions (2023-2028)
- 10.1.1 Global Pharmacogenomics Services Forecast by Regions (2023-2028)
- 10.1.2 Americas Pharmacogenomics Services Forecast
- 10.1.3 APAC Pharmacogenomics Services Forecast
- 10.1.4 Europe Pharmacogenomics Services Forecast
- 10.1.5 Middle East & Africa Pharmacogenomics Services Forecast
- 10.2 Americas Pharmacogenomics Services Forecast by Country (2023-2028)
- 10.2.1 United States Pharmacogenomics Services Market Forecast
- 10.2.2 Canada Pharmacogenomics Services Market Forecast
- 10.2.3 Mexico Pharmacogenomics Services Market Forecast
- 10.2.4 Brazil Pharmacogenomics Services Market Forecast
- 10.3 APAC Pharmacogenomics Services Forecast by Region (2023-2028)
- 10.3.1 China Pharmacogenomics Services Market Forecast
- 10.3.2 Japan Pharmacogenomics Services Market Forecast
- 10.3.3 Korea Pharmacogenomics Services Market Forecast
- 10.3.4 Southeast Asia Pharmacogenomics Services Market Forecast
- 10.3.5 India Pharmacogenomics Services Market Forecast
- 10.3.6 Australia Pharmacogenomics Services Market Forecast
- 10.4 Europe Pharmacogenomics Services Forecast by Country (2023-2028)
- 10.4.1 Germany Pharmacogenomics Services Market Forecast
- 10.4.2 France Pharmacogenomics Services Market Forecast
- 10.4.3 UK Pharmacogenomics Services Market Forecast
- 10.4.4 Italy Pharmacogenomics Services Market Forecast
- 10.4.5 Russia Pharmacogenomics Services Market Forecast
- 10.5 Middle East & Africa Pharmacogenomics Services Forecast by Region (2023-2028)
- 10.5.1 Egypt Pharmacogenomics Services Market Forecast
- 10.5.2 South Africa Pharmacogenomics Services Market Forecast
- 10.5.3 Israel Pharmacogenomics Services Market Forecast
- 10.5.4 Turkey Pharmacogenomics Services Market Forecast
- 10.5.5 GCC Countries Pharmacogenomics Services Market Forecast
- 10.6 Global Pharmacogenomics Services Forecast by Type (2023-2028)
- 10.7 Global Pharmacogenomics Services Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Abbott Laboratories
- 11.1.1 Abbott Laboratories Company Information
- 11.1.2 Abbott Laboratories Pharmacogenomics Services Product Offered
- 11.1.3 Abbott Laboratories Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Abbott Laboratories Main Business Overview
- 11.1.5 Abbott Laboratories Latest Developments
- 11.2 Admera Health, LLC
- 11.2.1 Admera Health, LLC Company Information
- 11.2.2 Admera Health, LLC Pharmacogenomics Services Product Offered
- 11.2.3 Admera Health, LLC Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Admera Health, LLC Main Business Overview
- 11.2.5 Admera Health, LLC Latest Developments
- 11.3 Mesa Laboratories, Inc.
- 11.3.1 Mesa Laboratories, Inc. Company Information
- 11.3.2 Mesa Laboratories, Inc. Pharmacogenomics Services Product Offered
- 11.3.3 Mesa Laboratories, Inc. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Mesa Laboratories, Inc. Main Business Overview
- 11.3.5 Mesa Laboratories, Inc. Latest Developments
- 11.4 Dynamic DNA Laboratories
- 11.4.1 Dynamic DNA Laboratories Company Information
- 11.4.2 Dynamic DNA Laboratories Pharmacogenomics Services Product Offered
- 11.4.3 Dynamic DNA Laboratories Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Dynamic DNA Laboratories Main Business Overview
- 11.4.5 Dynamic DNA Laboratories Latest Developments
- 11.5 F. Hoffmann-La Roche Ltd.
- 11.5.1 F. Hoffmann-La Roche Ltd. Company Information
- 11.5.2 F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Product Offered
- 11.5.3 F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 F. Hoffmann-La Roche Ltd. Main Business Overview
- 11.5.5 F. Hoffmann-La Roche Ltd. Latest Developments
- 11.6 GeneOmbio Technologies Pvt Ltd.
- 11.6.1 GeneOmbio Technologies Pvt Ltd. Company Information
- 11.6.2 GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Product Offered
- 11.6.3 GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 GeneOmbio Technologies Pvt Ltd. Main Business Overview
- 11.6.5 GeneOmbio Technologies Pvt Ltd. Latest Developments
- 11.7 Exact Sciences Corporation
- 11.7.1 Exact Sciences Corporation Company Information
- 11.7.2 Exact Sciences Corporation Pharmacogenomics Services Product Offered
- 11.7.3 Exact Sciences Corporation Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Exact Sciences Corporation Main Business Overview
- 11.7.5 Exact Sciences Corporation Latest Developments
- 11.8 Illumina, Inc.
- 11.8.1 Illumina, Inc. Company Information
- 11.8.2 Illumina, Inc. Pharmacogenomics Services Product Offered
- 11.8.3 Illumina, Inc. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Illumina, Inc. Main Business Overview
- 11.8.5 Illumina, Inc. Latest Developments
- 11.9 Laboratory Corporation of America Holdings
- 11.9.1 Laboratory Corporation of America Holdings Company Information
- 11.9.2 Laboratory Corporation of America Holdings Pharmacogenomics Services Product Offered
- 11.9.3 Laboratory Corporation of America Holdings Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 Laboratory Corporation of America Holdings Main Business Overview
- 11.9.5 Laboratory Corporation of America Holdings Latest Developments
- 11.10 Myriad Genetics, Inc.
- 11.10.1 Myriad Genetics, Inc. Company Information
- 11.10.2 Myriad Genetics, Inc. Pharmacogenomics Services Product Offered
- 11.10.3 Myriad Genetics, Inc. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 Myriad Genetics, Inc. Main Business Overview
- 11.10.5 Myriad Genetics, Inc. Latest Developments
- 11.11 OmeCare
- 11.11.1 OmeCare Company Information
- 11.11.2 OmeCare Pharmacogenomics Services Product Offered
- 11.11.3 OmeCare Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 OmeCare Main Business Overview
- 11.11.5 OmeCare Latest Developments
- 11.12 QIAGEN N.V.
- 11.12.1 QIAGEN N.V. Company Information
- 11.12.2 QIAGEN N.V. Pharmacogenomics Services Product Offered
- 11.12.3 QIAGEN N.V. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 QIAGEN N.V. Main Business Overview
- 11.12.5 QIAGEN N.V. Latest Developments
- 11.13 Quest Diagnostics Incorporated
- 11.13.1 Quest Diagnostics Incorporated Company Information
- 11.13.2 Quest Diagnostics Incorporated Pharmacogenomics Services Product Offered
- 11.13.3 Quest Diagnostics Incorporated Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.13.4 Quest Diagnostics Incorporated Main Business Overview
- 11.13.5 Quest Diagnostics Incorporated Latest Developments
- 11.14 Thermo Fisher Scientific Inc.
- 11.14.1 Thermo Fisher Scientific Inc. Company Information
- 11.14.2 Thermo Fisher Scientific Inc. Pharmacogenomics Services Product Offered
- 11.14.3 Thermo Fisher Scientific Inc. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.14.4 Thermo Fisher Scientific Inc. Main Business Overview
- 11.14.5 Thermo Fisher Scientific Inc. Latest Developments
- 11.15 Precipio
- 11.15.1 Precipio Company Information
- 11.15.2 Precipio Pharmacogenomics Services Product Offered
- 11.15.3 Precipio Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.15.4 Precipio Main Business Overview
- 11.15.5 Precipio Latest Developments
- 11.16 23andMe, Inc.
- 11.16.1 23andMe, Inc. Company Information
- 11.16.2 23andMe, Inc. Pharmacogenomics Services Product Offered
- 11.16.3 23andMe, Inc. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.16.4 23andMe, Inc. Main Business Overview
- 11.16.5 23andMe, Inc. Latest Developments
- 11.17 OneOme, LLC
- 11.17.1 OneOme, LLC Company Information
- 11.17.2 OneOme, LLC Pharmacogenomics Services Product Offered
- 11.17.3 OneOme, LLC Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.17.4 OneOme, LLC Main Business Overview
- 11.17.5 OneOme, LLC Latest Developments
- 11.18 DiaCarta, Inc.
- 11.18.1 DiaCarta, Inc. Company Information
- 11.18.2 DiaCarta, Inc. Pharmacogenomics Services Product Offered
- 11.18.3 DiaCarta, Inc. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.18.4 DiaCarta, Inc. Main Business Overview
- 11.18.5 DiaCarta, Inc. Latest Developments
- 11.19 OPKO Health
- 11.19.1 OPKO Health Company Information
- 11.19.2 OPKO Health Pharmacogenomics Services Product Offered
- 11.19.3 OPKO Health Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.19.4 OPKO Health Main Business Overview
- 11.19.5 OPKO Health Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Pharmacogenomics Services. Industry analysis & Market Report on Pharmacogenomics Services is a syndicated market report, published as Global Pharmacogenomics Services Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Pharmacogenomics Services market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
